Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey S McCombs

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cancer Treatment and Research Communications|August 26, 2022
Provider imaging practices and outcomes of advanced colorectal cancerHanke Zheng, Jeffrey S McCombs, Afsaneh Barzi
Journal of Affective Disorders|November 24, 2004
The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) programLizheng Shi, Patrick Thiebaud, Jeffrey S McCombs
Journal of Affective Disorders|October 26, 2010
Applying comparative effectiveness research methods in bipolar disordersJeffrey S McCombs, Vaidyanathan Ganapathy, Sara Zolfaghari
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2008
Duration of antipsychotic drug therapy in real-world practice: a comparison with CATIE trial resultsLei Chen, Jeffrey S McCombs, Jinhee Park
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 2, 2008
The impact of atypical antipsychotic medications on the use of health care by patients with schizophreniaLei Chen, Jeffrey S McCombs, Jinhee Park
Clinical Therapeutics|April 3, 2012
Effect of exenatide, pen insulin, and vial insulin on patient outcomes: a retrospective database analysis of persistence and first-year costs in a commercially insured populationNazia Rashid, Jeffrey S McCombs, Elizabeth Schwartz
Health Care Financing Review|July 3, 2004
Open access to innovative drugs: treatment substitutions or treatment expansion?Jeffrey S McCombs, Parvez Mulani, P Joseph Gibson
The American Journal of Managed Care|January 29, 2003
Effects of ambulatory-care pharmacist consultation on mortality and hospitalizationYong Yuan, Joel W Hay, Jeffrey S McCombs
CNS Drugs|March 15, 2017
A Retrospective Cohort Study of Acute Kidney Injury Risk Associated with AntipsychoticsYawen Jiang, Jeffrey S McCombs, Susie H Park
Journal of Affective Disorders|August 9, 2002
Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) programJinmei Li, Jeffrey S McCombs, Glen L Stimmel
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cancer Treatment and Research Communications|August 26, 2022
Provider imaging practices and outcomes of advanced colorectal cancerHanke Zheng, Jeffrey S McCombs, Afsaneh Barzi
Journal of Affective Disorders|November 24, 2004
The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) programLizheng Shi, Patrick Thiebaud, Jeffrey S McCombs
Journal of Affective Disorders|October 26, 2010
Applying comparative effectiveness research methods in bipolar disordersJeffrey S McCombs, Vaidyanathan Ganapathy, Sara Zolfaghari
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2008
Duration of antipsychotic drug therapy in real-world practice: a comparison with CATIE trial resultsLei Chen, Jeffrey S McCombs, Jinhee Park
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 2, 2008
The impact of atypical antipsychotic medications on the use of health care by patients with schizophreniaLei Chen, Jeffrey S McCombs, Jinhee Park
Clinical Therapeutics|April 3, 2012
Effect of exenatide, pen insulin, and vial insulin on patient outcomes: a retrospective database analysis of persistence and first-year costs in a commercially insured populationNazia Rashid, Jeffrey S McCombs, Elizabeth Schwartz
Health Care Financing Review|July 3, 2004
Open access to innovative drugs: treatment substitutions or treatment expansion?Jeffrey S McCombs, Parvez Mulani, P Joseph Gibson
The American Journal of Managed Care|January 29, 2003
Effects of ambulatory-care pharmacist consultation on mortality and hospitalizationYong Yuan, Joel W Hay, Jeffrey S McCombs
CNS Drugs|March 15, 2017
A Retrospective Cohort Study of Acute Kidney Injury Risk Associated with AntipsychoticsYawen Jiang, Jeffrey S McCombs, Susie H Park
Journal of Affective Disorders|August 9, 2002
Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) programJinmei Li, Jeffrey S McCombs, Glen L Stimmel
Pageof 3